LAVA Therapeutics N.V. (LVTX) Tops Q1 EPS by 29c

LAVA Therapeutics N.V. (NASDAQ: LVTX) reported Q1 EPS of ($0.02), $0.29 better than the analyst estimate of ($0.31). Revenue for the quarter came in at $6.99 million.

For earnings history and earnings-related data on LAVA Therapeutics N.V. (LVTX) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
• Goldman "broadly" raises estimates for LTL and truckload stocks